NORTHFIELD, Ill., NOV. 18, 2026—The College of American Pathologists (CAP) and the University of Pittsburgh’s Computational Pathology and AI Center of Excellence (CPACE) announced a strategic partnership to advance AI solutions that benefit CAP members and the broader pathology and laboratory communities.
Through this collaboration, the two organizations will identify areas where emerging AI technologies can improve efficiency, streamline knowledge management, and support education and professional development. In addition to developing, evaluating, and implementing these solutions, they will work together to improve access to the extensive resources and expertise available through the CAP.
“This partnership will help the CAP explore how AI can improve our operations, strengthen organizational capabilities, and enhance how we serve our members,” said CAP President Qihui “Jim” Zhai, MD, FCAP. “As we evaluate these opportunities, we will remain focused on rigorous assessment, human oversight, data security, and responsible governance.”
By combining the CAP’s leadership in laboratory accreditation, quality improvement, education, and advocacy with CPACE’s expertise in applied AI, the organizations aim to establish a collaborative model for the responsible integration of emerging AI technologies in professional medical organizations. Two innovative AI platforms developed through CPACE will serve as cornerstones of the partnership: Nebulon-GPT-Plus, also known as Pitt-GPT-Plus, and Pitt-AI-cademy.
- Nebulon-GPT-Plus is an advanced AI-powered conversational platform designed to deliver intelligent, context-aware assistance through large language models and knowledge retrieval technologies. It provides a flexible and scalable foundation for developing specialized AI assistants capable of interacting with complex, domain-specific information.
- Pitt-AI-cademy is a highly interactive, no-code AI education platform designed to make AI accessible to learners across a broad range of technical backgrounds and experience levels.
Together, these tools represent complementary approaches to advancing AI adoption, with the former providing the technological infrastructure to develop and deploy customized AI solutions and the latter building the knowledge, skills, and confidence needed to use AI effectively and responsibly. Through this partnership, these platforms will support the development of practical AI applications while expanding AI literacy, workforce readiness, and innovation across the pathology community.
For the CAP, Nebulon-GPT-Plus will provide a foundation for exploring AI-enabled applications tailored to organizational and member needs. Potential applications include intelligent navigation of CAP educational resources, support for internal administrative workflows, enhanced knowledge management, and AI-assisted access to information relevant to laboratory quality, accreditation, and professional practice. Pitt-AI-cademy is intended to help elevate the CAP team’s AI knowledge and readiness.
Beyond these AI tools, the partnership will explore additional AI platforms and technologies that can support operational analytics, workflow automation, decision support, and other emerging applications relevant to the CAP’s mission.
The partnership will also emphasize responsible AI implementation, including appropriate governance, data security, performance evaluation, human oversight, and ongoing monitoring. These principles will guide the development and adoption of AI applications to ensure they are aligned with the CAP’s organizational requirements and the expectations of its members.
###
About the CAP
As the world’s largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide.
About CPACE
The University of Pittsburgh’s Computational Pathology and AI Center of Excellence (CPACE) is one of the world’s first and largest centers dedicated to AI in pathology. Through multidisciplinary studies and initiatives, CPACE aims to transform medicine and improve patient outcomes by leveraging AI to detect disease earlier, more efficiently and more accurately.